RI
ROIV icon

RTW Investments’s Roivant Sciences ROIV Stock Holding History

RTW Investments’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,454,273
Closed -$17.2M – 78
2024
Q4 		$17.2M Hold
1,454,273
– – 0.26% 46
2024
Q3 		$16.8M Hold
1,454,273
– – 0.24% 48
2024
Q2 		$15.4M Hold
1,454,273
– – 0.24% 44
2024
Q1 		$15.3M Hold
1,454,273
– – 0.23% 52
2023
Q4 		$16.3M Sell
1,454,273
-98,444
-6% -$959K 0.26% 45
2023
Q3 		$18.1M Hold
1,552,717
– – 0.38% 39
2023
Q2 		$15.7M Hold
1,552,717
– – 0.3% 45
2023
Q1 		$11.5M Buy
1,552,717
+750,000
+93% +$6.18M 0.24% 41
2022
Q4 		$6.41M Hold
802,717
– – 0.13% 55
2022
Q3 		$2.58M Hold
802,717
– – 0.06% 78
2022
Q2 		$3.27M Hold
802,717
– – 0.08% 84
2022
Q1 		$3.96M Hold
802,717
– – 0.08% 81
2021
Q4 		$8.09M Buy
+802,717
New +$6.68M 0.12% 86

Other funds holding ROIV

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

RTW Investments's ROIV Position: Q1 2025 in Review

RTW Investments sold out of Roivant Sciences (ROIV) in Q1 2025, closing a stake of 1,454,273 shares — an estimated $17.2M sold.

RTW Investments first reported a position in ROIV in Q4 2021 and held it in 13 quarters. The position peaked at $18.1M in Q3 2023. 312 funds tracked by Wall St. Rank hold ROIV as of Q1 2025.

  • RTW Investments reported no remaining Roivant Sciences position as of Q1 2025 after selling out during the quarter.
  • RTW Investments sold 1,454,273 Roivant Sciences shares in Q1 2025, an estimated $17.2M.
  • RTW Investments first reported a position in Roivant Sciences in Q4 2021 and held it in 13 quarters.
  • RTW Investments's Roivant Sciences position peaked at $18.1M in Q3 2023.
  • 312 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2025.

Based on RTW Investments's 13F filing for Q1 2025, filed 15 May 2025.